Trial intelligence / Profile preview

Guided Discontinuation vs Maintenance of Sirolimus in Pediatric KHE

NCT04448873Phase 4Completed

Sponsor
Children's Hospital of Fudan University
Start
Jul 2020
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sirolimus in kaposiform hemangioendothelioma (KHE), sponsored by Children's Hospital of Fudan University. Started Jul 2020; status: completed.

02

Drugs

sirolimus
03

Conditions

kaposiform hemangioendothelioma (KHE)

Beyond the preview

Go deeper on NCT04448873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04448873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call